Latest Kymab Limited. Stories
Kymab Secures US$40 Million Investment From Two of the Largest Foundations in the World to Advance Clinical Development of Antibody Therapeutics
CAMBRIDGE, England, May 16, 2014 /PRNewswire/ -- Series B Financing includes the Wellcome Trust and the Bill & Melinda Gates Foundation Kymab, a monoclonal
Word of the Day
- A transitional zone between two communities containing the characteristic species of each.
The word 'ecotone' comes 'eco-' plus a Greek root meaning 'tension'.